Pharmacore secures funding to improve medication regimen reviews in long-term care
New ESW Guide Explains Copilot Studio Agent Pricing and the Controls to Set First
EMH Group modernises resident WiFi across its estate with Purple
TestMu AI Launches New Experience in KaneAI, Turning Recorded Tests into Objectives That Repair Themselves
Sweet Security Launches Virtual Patching to Protect Production Before Permanent Fixes Are Deployed
Toronto, Ontario–(Newsfile Corp. – June 15, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of preliminary ratings to 16 classes…
Mercury’s ROCK 4 mission computer Mercury’s ROCK 4, the first safety certifiable, small-form factor, ruggedized…
Toronto, Ontario–(Newsfile Corp. – June 15, 2023) – Sharechest is pleased to announce the recent…
Among industries, a great customer experience at a hotel leads to outsized loyalty, and a…
As global organizations look to centralize identity management through an open directory platform, JumpCloud solidifies…
Leuven, BELGIUM, Boston, MA, US – June 15, 2023 – 7 pm CET – Oxurion…
Veza Integration Ecosystem Enables Faster Deployment for the Enterprise PALO ALTO, Calif.–(BUSINESS WIRE)–#authorization—Veza, the identity…
Intelligent 360 degree view enables commercial fleet operators to improve efficiency, reduce costs, and protect…
LOS ANGELES–(BUSINESS WIRE)–MNTN, the Hardest Working Software in TV and a trailblazer in Performance TV…
Inaugural “State of Production Health” survey reveals that production health and supply chain optimization rank…
Vivoryon Therapeutics N.V. Announces CEO Transition Plan Dr. Ulrich Dauer not to extend current…
Vivoryon Therapeutics N.V. Announces CEO Transition Plan Dr. Ulrich Dauer not to extend current…
BOCA RATON, Fla., June 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First…
BOCA RATON, Fla., June 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First…
Promising reduction (>95%) in seizure frequency at the key one-year post treatment endpoint in the…
Promising reduction (>95%) in seizure frequency at the key one-year post treatment endpoint in the…
NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) — The Academy for Health and Lifespan Research…
— Application Includes Data from Phase III FRESCO-2 and FRESCO Clinical Trials, which Demonstrated Superiority of…
The holding company is backed by top investors including Peter Thiel and will focus on…